FDA-cleared profile

Diagnocat

DGNCT, LLC

Diagnocat is an automated concurrent-read aid for detecting periapical radiolucency on permanent teeth in previously acquired, clinically justified maxillofacial CBCT; it is a second-read aid and does not replace complete dental-professional review or judgment.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Diagnocat is an automated concurrent-read aid for detecting periapical radiolucency on permanent teeth in previously acquired, clinically justified maxillofacial CBCT; it is a second-read aid and does not replace complete dental-professional review or judgment.
FDA source Exact FDA submission Checked 2026-09-04
Intended users
Professionally trained and licensed dental professionals with at least two years of CBCT reading experience.
FDA source Exact FDA submission Checked 2026-09-04
Care setting and population
Dental and maxillofacial imaging workflows using clinically justified CBCT examinations.
FDA source Exact FDA submission Checked 2026-09-04
Workflow role
Automated concurrent second-read support for periapical-radiolucency detection on permanent teeth.
FDA source Exact FDA submission Checked 2026-09-04
Required input
Previously acquired, clinically justified maxillofacial CBCT studies of patients with permanent teeth.
FDA source Exact FDA submission Checked 2026-09-04
Output and human action
Tooth detection, localization or segmentation, and candidate periapical-radiolucency findings in a web or desktop review application.
FDA source Exact FDA submission Checked 2026-09-04
Limitations
Diagnocat is a second-read aid and does not replace complete dental review or clinical judgment. The cleared population, permanent dentition, maxillofacial CBCT, clinically justified acquisition, and trained-user limits apply.
FDA source Exact FDA submission Checked 2026-09-04

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K252934
FDA source Exact FDA submission Checked 2026-08-31
Modality
CBCT
FDA source Exact FDA submission Checked 2026-09-04
Anatomy
Maxillofacial region; permanent teeth; periapical radiolucency
FDA source Exact FDA submission Checked 2026-09-04
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2026-01-15
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The FDA package describes DICOM CBCT input and web or desktop outputs; exact local routing, viewer, archive, and reporting interfaces require testing.
FDA source Exact FDA submission Checked 2026-09-04
Deployment and data flow
The FDA package describes web and desktop application forms; current hosting, network, security, and local operational configuration remain unverified.
FDA source Exact FDA submission Checked 2026-09-04
Security and privacy
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

The FDA decision material does not establish the complete security posture for the exact product and deployment. Obtain architecture, identity, audit, encryption, retention, support-access, vulnerability-management, and incident-response evidence.

Training and support
Only professionally trained and licensed dental professionals with at least two years of cbct reading experience. should operate or interpret this product. Local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
FDA source Exact FDA submission Checked 2026-09-04
Monitoring and change control
Monitor K252934 by exact software, hardware, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Diagnocat is a second-read aid and does not replace complete dental review or clinical judgment. The cleared population, permanent dentition, maxillofacial CBCT, clinically justified acquisition, and trained-user limits apply.
FDA source Exact FDA submission Checked 2026-09-04

Release and scope verification

Map the installed product, build, options, population, anatomy, inputs, outputs, and enabled functions to K252934 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared release includes them.

Deployment boundary

The FDA package describes web and desktop application forms; current hosting, network, security, and local operational configuration remain unverified.

exact submission · checked 2026-09-04

FDA-described deployment details do not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The FDA package describes DICOM CBCT input and web or desktop outputs; exact local routing, viewer, archive, and reporting interfaces require testing.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Diagnocat is a second-read aid and does not replace complete dental review or clinical judgment. The cleared population, permanent dentition, maxillofacial CBCT, clinically justified acquisition, and trained-user limits apply.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price or product-specific reimbursement was established in the reviewed public material.

Lifecycle monitoring

Monitor K252934 by exact software, hardware, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Diagnocat is a second-read aid and does not replace complete dental review or clinical judgment. The cleared population, permanent dentition, maxillofacial CBCT, clinically justified acquisition, and trained-user limits apply.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
The FDA package documents automated tooth and periapical-radiolucency analysis verification for the cleared concurrent-read workflow; no exact-version independent outcome claim was promoted.
FDA source Exact FDA submission Checked 2026-09-04
Reported sensitivity
85.4%
Public source Exact FDA submission Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
99.1%
Public source Exact FDA submission Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K252934 FDA evidence package for Diagnocat

FDA 510(k) verification and validation evidence described in the exact submission · Maxillofacial region; permanent teeth; periapical radiolucency

exact submission · Tested version: Diagnocat · Sponsor or vendor study

K252934

Manufacturer evidence submitted for the exact FDA decision. It is not independent clinical validation, and local technical, clinical, privacy, security, and workflow acceptance remains necessary.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No public list price for the exact cleared product version was established. Obtain a written quote separating license, implementation, interfaces, compute, storage, training, support, upgrades, renewal, and exit costs.

Reimbursement and coding
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
Public source Not applicable Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed CMS material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Verify payer, site-of-service, coding, and coverage assumptions independently.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no candidate record for K252934; no exact native submission identifier match was found.
Public source Exact FDA submission Checked 2026-09-04

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-04Last searched
25Fields reviewed
10Source classes checked
20Reviewed PubMed leads
1Reviewed trial leads
0Unreviewed FDA recall leads

Screened 20 PubMed titles and one trial record. Some concern dental AI, CBCT, or periapical radiolucency, but none identifies Diagnocat, K252934, and the tested release; all 21 are quarantined. The current discovery snapshot contains 20 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-04.

Alternatives

Related tools to compare

FDA-cleared K260785

DS Core CBCT Anatomy

Dentsply Sirona

DS Core CBCT Anatomy uses CBCT and digital-impression data to provide tooth and jaw segmentation, inferior-alveolar-nerve-canal segmentation, panoramic-curve support, and...

Modality
CBCT
Anatomy
Teeth; jaws; and the inferior alveolar nerve canal
Decision
2026-04-23
FDA-cleared K252538

CEPHX3D

Orca Dental AI, Ltd.

CEPHX3D processes dental and craniomaxillofacial images to support diagnosis and treatment planning, including three-dimensional models, viewing, segmentation, measurements, and...

Modality
CBCT
Anatomy
Dental and craniomaxillofacial anatomy
Decision
2026-03-05
FDA-cleared K253009

DS Core Detect

Dentsply Sirona, Inc.

FDA product code MYN identifies this device class as Analyzer, Medical Image. For information on the MYN device, please see:...

Modality
CBCT
Anatomy
N/A
Decision
2026-01-07
FDA-cleared K251514

Overjet CBCT Assist

Overjet, Inc.

Dental and craniomaxillofacial CBCT segmentation, measurement and visualization support

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2025-12-05